# Donanemab

NDC: 43624-044
Generic name: Donanemab
Labeler / Manufacturer: BSP Pharmaceuticals S.p.A.
Product type: DRUG FOR FURTHER PROCESSING
Marketing category: DRUG FOR FURTHER PROCESSING
Dosage form: INJECTION, SOLUTION
Routes: —
Marketing started: 20260922



## Active ingredients

- DONANEMAB: 17.5 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"43624-044"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=43624-044